Rogério Salinas Ferreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rogério Salinas Ferreira has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Denise Carleto Andia
Dental Research Division Paulista University Sao Paulo Brazil
3 shared publications - Rahyza Inácio Freire de Assis
Department of Prosthodontics and Periodontics, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil
3 shared publications - Geórgia da Silva Feltran
Department of Chemistry and Biochemistry, Lab. of Bioassays and Cellular Dynamics, Institute of Biosciences, UNESP - São Paulo State University, Botucatu, Brazil
2 shared publications - Rodrigo Augusto da Silva
Health Science Post‐Graduate Program University of Taubaté – UNITAU Taubaté Brazil
2 shared publications - Willian Fernando Zambuzzi
Bioassays and Cell Dynamics Lab, Dept. of Chemistry and Biochemistry, Bioscience Institute, UNESP, Botucatu, 18603-100, Sao Paulo, Brazil
2 shared publications - Ana Carolina Bontempi
Dental Research Division, School of Dentistry, Paulista University - UNIP, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 2 April 2026
- Published by Elsevier in Differentiation
- Vol. 149, 100960
Resveratrol modulates Hedgehog signaling pathway and increases the osteogenic commitment of periodontal ligament mesenchymal cells
- 2 April 2026
- Published by Elsevier in Differentiation
- Vol. 149, 100960
Open AccessResveratrol modulates Hedgehog signaling pathway and increases the osteogenic commitment of periodontal ligament mesenchymal cells
- 22 November 2023
- Published by Wiley in Oral Diseases
- Vol. 30 (6) , 3971-3981
JARID1B represses the osteogenic potential of human periodontal ligament mesenchymal cells
Background: Here, we evaluated whether the histone lysine demethylase 5B (JARID1B), is involved in osteogenic phenotype commitment of periodontal ligament cells (PDLCs), by considering their heterogeneity for osteoblast differentiation. Materials and Methods: Epigenetic, transcriptional, and protein levels of a gene set, involved in the osteogenesis, were investigated by performing genome‐wide DNA (hydroxy)methylation, mRNA expression, and western blotting analysis at basal (without osteogenic induction), and at the 3rd and 10th days of osteogenic stimulus, in vitro, using PDLCs with low (l) and high (h) osteogenic potential as biological models. Results: h‐PDLCs showed reduced levels of JARID1B , compared to l‐PDLCs, with significant inversely proportional correlations between RUNX2 and RUNX2/p57 . Epigenetically, a significant reduction in the global H3K4me3 content was observed only in h‐PDLCs. Immunoblotting data reveal a significant reduction in the global H3K4me3 content, at 3 days of induction only in h‐PDLCs, while an increase in the global H3K4me3 content was observed at 10 days for both PDLCs. Additionally, positive correlations were found between global H3K4me3 levels and JARID1B gene expression. Conclusions: Altogether, our results show the crucial role of JARID1B in repressing PDLCs osteogenic phenotype and this claims to pre‐clinical protocols proposing JARID1B as a potential therapeutic target.
- 22 November 2023
- Published by Wiley in Oral Diseases
- Vol. 30 (6) , 3971-3981
JARID1B represses the osteogenic potential of human periodontal ligament mesenchymal cells
Background: Here, we evaluated whether the histone lysine demethylase 5B (JARID1B), is involved in osteogenic phenotype commitment of periodontal ligament cells (PDLCs), by considering their heterogeneity for osteoblast differentiation. Materials and Methods: Epigenetic, transcriptional, and protein levels of a gene set, involved in the osteogenesis, were investigated by performing genome‐wide DNA (hydroxy)methylation, mRNA expression, and western blotting analysis at basal (without osteogenic induction), and at the 3rd and 10th days of osteogenic stimulus, in vitro, using PDLCs with low (l) and high (h) osteogenic potential as biological models. Results: h‐PDLCs showed reduced levels of JARID1B , compared to l‐PDLCs, with significant inversely proportional correlations between RUNX2 and RUNX2/p57 . Epigenetically, a significant reduction in the global H3K4me3 content was observed only in h‐PDLCs. Immunoblotting data reveal a significant reduction in the global H3K4me3 content, at 3 days of induction only in h‐PDLCs, while an increase in the global H3K4me3 content was observed at 10 days for both PDLCs. Additionally, positive correlations were found between global H3K4me3 levels and JARID1B gene expression. Conclusions: Altogether, our results show the crucial role of JARID1B in repressing PDLCs osteogenic phenotype and this claims to pre‐clinical protocols proposing JARID1B as a potential therapeutic target.
- 22 July 2021
- Published by Wiley in Journal of Periodontology
- Vol. 93 (3) , 435-448
Genome‐wide DNA (hydroxy) methylation reveals the individual epigenetic landscape importance on osteogenic phenotype acquisition in periodontal ligament cells
Background: Mesenchymal cells’ biology has been an important investigative tool to maximize bone regeneration through tissue engineering. Here we used mesenchymal cells from periodontal ligament (PDLCs) with high (h‐) and low (l‐) osteogenic potential, isolated from different donors, to investigate the impact of the individual epigenetic and transcriptional profiles on the osteogenic potential.Methods: Genome‐wide and gene‐specific DNA (hydroxy) methylation, mRNA expression and immunofluorescence analysis were carried out in h‐ and l‐PDLCs at DMEM (non‐induced to osteogenesis) and OM (induced—3rd and 10th days of osteogenic differentiation) groups in vitro.Results: Genome‐wide results showed distinct epigenetic profile among PDLCs with most of the differences on 10th day of OM; DMEMs showed higher concentrations (xOM) of differentially methylated probes in gene body, intronic and open sea (3rd day), increasing this concentration in TSS200 and island regions, at 10 days. At basal levels, h‐ and l‐PDLCs showed different transcriptional profiles; l‐PDLCs demonstrated higher levels of NANOG/OCT4/SOX2, BAPX1, DNMT3A, TET1/3, and lower levels of RUNX2 transcripts, confirmed by NANOG/OCT4 and RUNX2 immunofluorescence. After osteogenic induction, the distinct transcriptional profile of multipotentiality genes was maintained among PDLCs. In l‐PDLCs, the anti‐correlation between DNA methylation and gene expression in RUNX2 and NANOG indicates methylation could play a role in modulating both transcripts.Conclusions: Epigenetic and transcriptional distinct profiles detected at basal levels among PDLCs were maintained after osteogenic induction. We cannot discard the existence of a complex that represses osteogenesis, suggesting the individual donors’ characteristics have significant impact on the osteogenic phenotype acquisition.
- 22 July 2021
- Published by Wiley in Journal of Periodontology
- Vol. 93 (3) , 435-448
Genome‐wide DNA (hydroxy) methylation reveals the individual epigenetic landscape importance on osteogenic phenotype acquisition in periodontal ligament cells
Background: Mesenchymal cells’ biology has been an important investigative tool to maximize bone regeneration through tissue engineering. Here we used mesenchymal cells from periodontal ligament (PDLCs) with high (h‐) and low (l‐) osteogenic potential, isolated from different donors, to investigate the impact of the individual epigenetic and transcriptional profiles on the osteogenic potential.Methods: Genome‐wide and gene‐specific DNA (hydroxy) methylation, mRNA expression and immunofluorescence analysis were carried out in h‐ and l‐PDLCs at DMEM (non‐induced to osteogenesis) and OM (induced—3rd and 10th days of osteogenic differentiation) groups in vitro.Results: Genome‐wide results showed distinct epigenetic profile among PDLCs with most of the differences on 10th day of OM; DMEMs showed higher concentrations (xOM) of differentially methylated probes in gene body, intronic and open sea (3rd day), increasing this concentration in TSS200 and island regions, at 10 days. At basal levels, h‐ and l‐PDLCs showed different transcriptional profiles; l‐PDLCs demonstrated higher levels of NANOG/OCT4/SOX2, BAPX1, DNMT3A, TET1/3, and lower levels of RUNX2 transcripts, confirmed by NANOG/OCT4 and RUNX2 immunofluorescence. After osteogenic induction, the distinct transcriptional profile of multipotentiality genes was maintained among PDLCs. In l‐PDLCs, the anti‐correlation between DNA methylation and gene expression in RUNX2 and NANOG indicates methylation could play a role in modulating both transcripts.Conclusions: Epigenetic and transcriptional distinct profiles detected at basal levels among PDLCs were maintained after osteogenic induction. We cannot discard the existence of a complex that represses osteogenesis, suggesting the individual donors’ characteristics have significant impact on the osteogenic phenotype acquisition.